calendar
18,993 catalysts · 18,987 approval · 5,256 phase readout · 5,000 device 510k · 4,728 grant · 2,563 8k filing · 2,000 device pma
next 91 dayslessmore
MonWedFri
18,993 catalysts · 18,987 approval · 5,256 phase readout · 5,000 device 510k · 4,728 grant · 2,563 8k filing · 2,000 device pma
Sponsor: SANDOZ. Form: EMULSION. Route: OPHTHALMIC
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: ENDO OPERATIONS. Form: IMPLANT. Route: SUBCUTANEOUS
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SANDOZ. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: HARROW EYE. Form: SUSPENSION. Route: OPHTHALMIC
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: LONG GROVE PHARMS. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SUSPENSION. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: GENUS LIFESCIENCES. Form: SOLUTION. Route: ORAL
Sponsor: HISAMITSU PHARM CO. Form: PATCH. Route: TOPICAL
Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS. Form: SOLUTION. Route: INHALATION
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL